Search

everythinglearnresearchcommunity

for

Search:↓

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Most women with excess hair growth had Polycystic Ovary Syndrome, and severity wasn't linked to hormone levels.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Prenatal stress changes how male and female rats enjoy rewards differently, linked to sex hormones.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Women with irregular periods and/or excessive body hair are more likely to have polycystic ovaries, and this condition is linked to higher health risks.

The method can measure multiple steroids in human hair to study long-term steroid metabolism, especially in newborns and children.

A woman's increased hair growth during pregnancy due to PCOS resolved after delivery.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

FAI is a better marker for predicting female hair loss than testosterone or SHBG alone.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Certain hormone treatments can increase SBP levels and help with mild body hair growth.

Most men with Frontal fibrosing alopecia also lose facial hair and the condition may be linked to hormone levels and sunscreen use.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

A very-low-calorie diet led to more weight loss and health improvements in obese women with PCOS than a moderate energy deficit diet.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Sex hormones affect liver fat and metabolic health differently in men and women.

Dihydrotestosterone boosts inflammation in fat cells more than testosterone.

Quercetin may help improve symptoms of polycystic ovary syndrome.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

Probiotic supplements may help reduce inflammation and oxidative stress in women with PCOS.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.